7.5mg Mounjaro to Wegovy Switch Guide | Cured Pharmacy

Clinically Proven UK Registered Pharmacy

Cheapest Switching from 7.5mg Mounjaro to Wegovy UK £200.00

Get the cheapest UK price when switching from Mounjaro 7.5mg to Wegovy, plus £20 off your first order with code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

WEIGHTLOSSNEW £20 off for new customers

Treatment from £124.99

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check if you're eligible

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£99 £79.00

£19.75 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £99
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy Oral Pill
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy Oral Pill
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy Oral Pill
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy Oral Pill
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Cheapest Switching from 7.5mg Mounjaro to Wegovy UK: Compare Both

Published on: June 03, 2026

If you're considering switching from 7.5mg Mounjaro to Wegovy UK, understanding the key differences between these two GLP-1 receptor agonists is essential for making an informed decision with your prescriber. Both medications are MHRA-licensed for weight management in the UK, but they work through different mechanisms and offer distinct clinical profiles. At Cured Pharmacy, our UK-registered clinical team can assess your suitability for either treatment through a free online consultation, with Mounjaro available from £124.99 and Wegovy from £135.00.

Understanding 7.5mg Mounjaro: Clinical Profile and Efficacy

If you're considering switching from 7.5mg Mounjaro to Wegovy UK, understanding the key differences between these two GLP-1 receptor agonists is essential for making an informed decision with your prescriber. Both medications are MHRA-licensed for weight management in the UK, but they work through different mechanisms and offer distinct clinical profiles. At Cured Pharmacy, our UK-registered clinical team can assess your suitability for either treatment through a free online consultation, offering the cheapest switching from 7.5mg Mounjaro to Wegovy UK, with Mounjaro available from £124.99 and Wegovy from £135.00.

In the SURMOUNT-1 trial, participants receiving tirzepatide 10mg or 15mg (the doses following 7.5mg escalation) achieved average body weight reductions of 19.5% and 20.9% respectively over 72 weeks [1]. Patients on the 7.5mg maintenance dose typically experience substantial appetite suppression and steady weight loss, though many prescribers continue escalation to higher doses for optimal results. The dual-receptor mechanism distinguishes Mounjaro from single-pathway GLP-1 treatments, potentially explaining its superior weight loss outcomes in head-to-head comparisons.

Common side effects at the 7.5mg dose include nausea (reported in approximately 20-25% of patients), diarrhoea, constipation, and reduced appetite [1]. These gastrointestinal effects typically diminish over 4-8 weeks as the body adjusts to the medication. Most patients on 7.5mg Mounjaro find these effects manageable, though individual tolerance varies considerably.

Wegovy (Semaglutide): Mechanism and Clinical Evidence

Wegovy contains semaglutide, a selective GLP-1 receptor agonist that has been extensively studied for weight management in the UK and internationally [2]. Unlike Mounjaro's dual-receptor approach, Wegovy works exclusively through GLP-1 pathway activation, slowing gastric emptying, reducing appetite, and improving glycaemic control. The medication follows a structured dose escalation protocol, starting at 0.25mg weekly and increasing gradually to the maintenance dose of 2.4mg over 16-20 weeks.

The STEP 1 trial demonstrated that participants receiving semaglutide 2.4mg achieved an average body weight reduction of 14.9% over 68 weeks, compared to 2.4% with placebo [2]. While this represents significant clinical efficacy, direct comparison trials suggest tirzepatide may produce approximately 5-7 percentage points greater weight loss than semaglutide at equivalent treatment durations [3]. However, individual response varies, and some patients achieve excellent outcomes with Wegovy whilst experiencing fewer side effects than with dual-receptor agonists.

Wegovy's side effect profile closely mirrors other GLP-1 agonists, with nausea being the most commonly reported adverse effect (occurring in approximately 44% of participants during dose escalation) [2]. Most gastrointestinal symptoms resolve within the first 8-12 weeks of treatment. The medication has been available in the UK since 2023 and benefits from extensive real-world safety data accumulated through its earlier use for type 2 diabetes management under the brand name Ozempic.

Cardiovascular Benefits of Semaglutide

One notable advantage of semaglutide is the robust cardiovascular outcomes data supporting its use. The SELECT trial demonstrated that semaglutide 2.4mg reduced major adverse cardiovascular events by 20% in adults with established cardiovascular disease and overweight or obesity [4]. This cardiovascular benefit may influence prescriber decision-making for patients with existing heart disease or significant cardiovascular risk factors, though ongoing trials are evaluating tirzepatide's cardiovascular effects as well.

Switching from 7.5mg Mounjaro to Wegovy: Dosing Equivalence

There is no direct dose equivalence between tirzepatide and semaglutide due to their different receptor mechanisms and pharmacokinetic profiles. However, clinical guidance suggests that patients switching from Mounjaro 7.5mg to Wegovy would typically transition to the full maintenance dose of semaglutide 2.4mg, rather than starting the entire Wegovy escalation schedule from 0.25mg. This approach recognises that patients already established on a GLP-1-based therapy have developed tolerance to the class-wide gastrointestinal effects.

Your UK prescriber will determine the appropriate starting dose based on several factors: how long you've been on Mounjaro 7.5mg, your current side effect profile, your weight loss trajectory, and any concurrent medical conditions. Some prescribers may recommend a brief intermediate step at Wegovy 1.7mg for 2-4 weeks before advancing to 2.4mg, particularly if you've experienced significant nausea or vomiting on Mounjaro. This individualised approach minimises the risk of treatment discontinuation due to side effects whilst maintaining therapeutic momentum.

Head-to-head comparison data suggests tirzepatide generally produces greater absolute weight loss than semaglutide, though both medications demonstrate clinically significant efficacy. A network meta-analysis published in 2023 found that tirzepatide 15mg resulted in approximately 5-7 percentage points greater body weight reduction compared to semaglutide 2.4mg at 40-72 week timepoints [3]. However, this population-level data doesn't predict individual response, and some patients seek the cheapest switching from 7.5mg Mounjaro to Wegovy UK and achieve their weight loss goals more comfortably on Wegovy than on higher Mounjaro doses.

Practical Considerations During the Transition

During the first 4-6 weeks after switching to Wegovy, monitor for any changes in side effects or appetite control. Some patients report that Wegovy produces less nausea than Mounjaro, whilst others find the appetite suppression slightly less pronounced. Keep a brief symptom diary and maintain regular contact with your prescriber to optimise your dose if needed. If you experience significant side effects, your prescriber may temporarily reduce your Wegovy dose before re-escalating, rather than discontinuing treatment entirely.

Feature Mounjaro (Tirzepatide) Wegovy (Semaglutide)
Active Ingredient Tirzepatide (dual GIP/GLP-1 agonist) Semaglutide (GLP-1 agonist)
Injection Frequency Once weekly Once weekly
Maintenance Dose Range 7.5mg to 15mg weekly 2.4mg weekly
Average Weight Loss (clinical trials) Up to 20.9% over 72 weeks 14.9% over 68 weeks
Starting Price at Cured Pharmacy From £69.00 From £69.00
Dose Escalation Period 20 weeks to maximum dose 16-20 weeks to maintenance dose
Most Common Side Effects Nausea, diarrhoea, constipation Nausea, diarrhoea, constipation
Cardiovascular Outcomes Data Trials ongoing 20% reduction in MACE (SELECT trial)
MHRA Licensed for Weight Management Yes Yes

Comparing Efficacy: Which Medication Produces Greater Weight Loss?

Head-to-head comparison data suggests tirzepatide generally produces greater absolute weight loss than semaglutide, though both medications demonstrate clinically significant efficacy. A network meta-analysis published in 2023 found that tirzepatide 15mg resulted in approximately 5-7 percentage points greater body weight reduction compared to semaglutide 2.4mg at 40-72 week timepoints [3]. However, this population-level data doesn't predict individual response, and some patients achieve their weight loss goals more comfortably on Wegovy than on higher Mounjaro doses.

It's important to recognise that medication choice represents only one component of successful weight management. Patients who engage with structured lifestyle modification programmes, maintain consistent physical activity, and address behavioural eating patterns typically achieve superior outcomes regardless of which GLP-1 medication they use. The 'best' medication is the one you can tolerate consistently whilst maintaining healthy lifestyle habits and regular prescriber follow-up.

If you've reached a weight loss plateau on Mounjaro 7.5mg, switching to Wegovy may not necessarily overcome this stall. Plateaus typically reflect metabolic adaptation rather than medication inadequacy, and many patients benefit more from escalating to Mounjaro 10mg or 15mg rather than switching medications entirely. Your UK prescriber can help interpret your weight loss trajectory and determine whether switching, escalating, or modifying your lifestyle approach offers the best path forward.

Side Effects Comparison: What to Expect When Switching

Both Mounjaro and Wegovy share similar side effect profiles due to their GLP-1 receptor activity, though the addition of GIP agonism in tirzepatide may influence the frequency and severity of certain adverse effects. The most common side effects for both medications include nausea, diarrhoea, constipation, abdominal pain, vomiting, and injection site reactions [1][2]. These effects are typically most pronounced during dose escalation and tend to diminish over time as physiological tolerance develops.

Some patients report that switching from Mounjaro to Wegovy reduces nausea and gastrointestinal discomfort, whilst others experience no significant difference in tolerability. Individual variation in drug metabolism, gut microbiome composition, and sensitivity to appetite hormone signalling likely explains these differing experiences. If you've tolerated Mounjaro 7.5mg well, you'll probably tolerate Wegovy 2.4mg equally well, though there are no guarantees.

Medication cost represents a significant consideration for most patients managing chronic weight, particularly given that these treatments require ongoing use to maintain weight loss. At Cured Pharmacy, we offer the cheapest switching from 7.5mg Mounjaro to Wegovy UK, with Wegovy available from £135.00 per month and Mounjaro from £124.99. Both prices include your medication, UK prescriber consultation, and discreet delivery to your address.

Managing Side Effects During the Transition

To minimise side effects when switching to Wegovy, eat smaller, more frequent meals, avoid high-fat foods that delay gastric emptying, stay well-hydrated, and inject your medication at the same time each week. If nausea occurs, ginger tea, small amounts of bland carbohydrates, and anti-nausea medication (prescribed by your doctor if needed) can provide relief. Most gastrointestinal symptoms resolve within 4-8 weeks as your body adjusts to the new medication.

Cost Considerations and Accessing Treatment Through Cured Pharmacy

Medication cost represents a significant consideration for most patients managing chronic weight, particularly given that these treatments require ongoing use to maintain weight loss. At Cured Pharmacy, Wegovy is available from £135.00 per month, offering competitive UK pricing for patients seeking semaglutide treatment. Mounjaro is available from £124.99 reflecting the medication's dual-receptor mechanism and more recent market entry. Both prices include your medication, UK prescriber consultation, and discreet delivery to your address.

When evaluating cost, consider the complete treatment journey rather than isolated monthly expenses. Some patients achieve their weight loss goals more rapidly on higher-efficacy medications despite higher per-dose costs, potentially reducing total treatment duration and lifetime expenditure. Conversely, others prefer starting with lower-cost options and escalating only if needed. Your UK prescriber at Cured Pharmacy can discuss cost-effective treatment strategies that align with your clinical needs and financial circumstances.

All prescription weight loss medications at Cured Pharmacy require completion of a free online clinical assessment by a UK-registered prescriber. This typically takes under three minutes and evaluates your medical history, current medications, weight loss goals, and any contraindications to GLP-1 therapy. If approved, your medication is dispensed by our GPhC-registered pharmacy (registration number 9012511) under the supervision of superintendent pharmacist Tarun Kumar (GPhC 2233073), with discreet delivery typically within 2-3 working days.

Scientific References

  1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., Kiyosue, A., Zhang, S., Liu, B., Bunck, M. C., Stefanski, A., & SURMOUNT-1 Investigators. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–218. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
  2. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., Wharton, S., Yokote, K., Zeuthen, N., Kushner, R. F., & STEP 1 Study Group. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
  3. Shi, Q., Nong, K., Vandvik, P. O., Guyatt, G. H., Schnell, O., Rydén, L., Marx, N., Brosius, F. C., Mustafa, R. A., & Agarwal, A. (2023). Benefits and harms of drug treatment for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials. BMJ, 381, e074068. https://doi.org/10.1136/bmj-2022-074068 [accessed 13 August 2026]
  4. Lincoff, A. M., Brown-Frandsen, K., Colhoun, H. M., Deanfield, J., Emerson, S. S., Esbjerg, S., Hardt-Lindberg, S., Hovingh, G. K., Kahn, S. E., Kushner, R. F., Lingvay, I., Oral, T. K., Michelsen, M. M., Plutzky, J., Tornøe, C. W., Ryan, D. H., & SELECT Trial Investigators. (2023). Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. New England Journal of Medicine, 389(24), 2221–2232. https://doi.org/10.1056/NEJMoa2307563 [accessed 13 August 2026]
  5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
  6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
  7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication or switching between treatments. Individual results may vary, and weight loss outcomes depend on multiple factors including lifestyle modification, adherence, and individual metabolic response.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

Can I switch directly from Mounjaro 7.5mg to Wegovy 2.4mg?
Most UK prescribers will transition patients directly to Wegovy 2.4mg or an intermediate dose like 1.7mg, rather than restarting the full escalation schedule from 0.25mg. For the cheapest switching from 7.5mg Mounjaro to Wegovy UK, your prescriber will determine the safest approach based on your individual tolerance and medical history.
Will I regain weight when switching from Mounjaro to Wegovy?
If you transition seamlessly between medications without a treatment gap, weight regain is unlikely. Both medications work through GLP-1 pathways, maintaining appetite suppression and metabolic benefits throughout the switch.
Is Wegovy less effective than Mounjaro for weight loss?
Clinical trial data suggests tirzepatide produces approximately 5-7 percentage points greater weight loss than semaglutide on average, though individual responses vary considerably. Many patients achieve excellent results with Wegovy and may tolerate it better than higher Mounjaro doses.
How long should I wait between my last Mounjaro injection and first Wegovy dose?
Most prescribers recommend administering your first Wegovy injection one week after your final Mounjaro dose, maintaining the weekly schedule without interruption. No washout period is typically required.
Will switching to Wegovy reduce my side effects from Mounjaro?
Some patients report fewer gastrointestinal side effects with Wegovy compared to Mounjaro, whilst others notice no significant difference. Individual variation makes it difficult to predict your specific experience.
Can I switch back to Mounjaro if Wegovy doesn't work for me?
Yes, patients can switch between GLP-1 medications under prescriber supervision if one proves more suitable than another. Your UK prescriber will guide you through any medication changes based on your response and tolerability.
Do I need a new prescription to switch from Mounjaro to Wegovy?
Yes, Mounjaro and Wegovy are distinct prescription medications requiring separate prescriptions. You'll need to complete a clinical assessment with a UK prescriber at Cured Pharmacy to obtain a Wegovy prescription.
Which medication is better for patients with cardiovascular disease?
Wegovy has demonstrated cardiovascular benefits in the SELECT trial, reducing major adverse cardiovascular events by 20%. This evidence may influence prescriber recommendations for patients with established heart disease, though tirzepatide trials are ongoing. Cured Pharmacy offers the cheapest switching from 7.5mg Mounjaro to Wegovy UK with full clinical support.
What Wegovy dose should I start on when switching from 7.5mg Mounjaro?
When switching from 7.5mg Mounjaro to Wegovy in the UK, most prescribers recommend starting at Wegovy 1.7mg or 2.4mg to maintain similar efficacy. Cured Pharmacy's UK-registered clinicians will assess your individual response to Mounjaro 7.5mg and recommend the most appropriate Wegovy starting dose during your online consultation.
How long should I wait between my last Mounjaro 7.5mg dose and starting Wegovy?
You should typically wait 7 days after your last Mounjaro 7.5mg injection before starting Wegovy to avoid overlapping dual GLP-1 receptor agonist therapy. Cured Pharmacy's prescribers will provide personalised guidance on the safest transition timeline based on your treatment history and any side effects experienced on Mounjaro.
Will I lose the weight loss progress I made on Mounjaro 7.5mg when switching to Wegovy?
Most patients maintain their weight loss when switching from 7.5mg Mounjaro to Wegovy, especially when transitioning to an equivalent Wegovy dose like 1.7mg or 2.4mg. Cured Pharmacy recommends continuing healthy eating and exercise habits during the switch to optimise results and minimise any temporary plateau in weight loss.
Is Wegovy cheaper than Mounjaro 7.5mg in the UK?
Yes, Wegovy is significantly cheaper than Mounjaro 7.5mg in the UK. At Cured Pharmacy, Wegovy 2.4mg costs £179.00 compared to £200.00 for Mounjaro 7.5mg, and you can save an additional £20 off your first Wegovy order with code Weightlossnew, making the switch more affordable.
Can I switch back to Mounjaro if Wegovy doesn't work as well for me?
Yes, you can switch back to Mounjaro 7.5mg if Wegovy is less effective for your weight loss goals, though most patients find similar results with the correct Wegovy dose. Cured Pharmacy's UK clinicians offer ongoing support and can adjust your treatment plan, including switching back to Mounjaro, if needed during your weight loss journey. We also provide the cheapest switching from 7.5mg Mounjaro to Wegovy UK for patients exploring their options.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 13 August 2026

Last updated on 13 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 13 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (13 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.